Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2020

Nov 20, 2020

30893_dirs_2020-11-20_a6f51ffc-39b3-4405-bc8a-b6cb2748c66a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2020-11-18

Reporting Person: Downing Steven R (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-18 Common Stock M 13504.00 $15.50 Acquired 146679.00 Direct
2020-11-18 Common Stock M 15000.00 $13.385 Acquired 161679.00 Direct
2020-11-18 Common Stock S 28504.00 $33.1897 Disposed 133175.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-18 Employee Stock Option (Right to buy) $15.50 M 13504.00 Disposed 2022-09-30 Common Stock (13504.00) Direct
2020-11-18 Employee Stock Option (Right to buy) $13.385 M 15000.00 Disposed 2021-09-30 Common Stock (15000.00) Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F2: This transaction was executed in multiple trades at prices ranging from $33.09 to $33.30. The price reported above reflects the weighted average price.

F3: Options are fully vested.